Human Metabolome Technologies Inc 6090.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
646.00quote price arrow up+78.00 (+13.73%)
Volume
555,600
52 week range
545.00 - 1,044.00
Loading...
  • Open591.00
  • Day High668.00
  • Day Low581.00
  • Prev Close568.00
  • 52 Week High1,044.00
  • 52 Week High Date07/08/21
  • 52 Week Low545.00
  • 52 Week Low Date02/25/22

Key Stats

  • Market Cap26.85M
  • Shares Out5.9M
  • 10 Day Average Volume9,587.5
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change0.16

KEY STATS

  • Open591.00
  • Day High668.00
  • Day Low581.00
  • Prev Close568.00
  • 52 Week High1,044.00
  • 52 Week High Date07/08/21
  • 52 Week Low545.00
  • 52 Week Low Date02/25/22
  • Market Cap26.85M
  • Shares Out5.9M
  • 10 Day Average Volume9,587.5
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change0.16

RATIOS/PROFITABILITY

  • EPS (TTM)20.30
  • P/E (TTM)31.82
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Human Metabolome Technologies Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Human Metabolome Technologies, Inc. is a Japan-based biotechnology company developing capillary electrophoresis mass spectrometry (CE-MS) based metabolomics technologies and solutions. The Company operates in two segments. The Metabolome Analysis segment engages in the provision of analysis service that analyzes metabolomics of measurement samples and reports the results to customers. The Biomarker segment is engaged in the exploration of biomarkers, and the research and...
Ryuji Kanno
Chairman of the Board
Katsuhito Hashizune
President, President of Subsidiary, Representative Director
Address
246-2, Mizukami, Kakuganji
Tsuruoka-shi, YMG
997-0052
Japan